{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:45:45Z","timestamp":1780098345025,"version":"3.54.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/cad.0b013e328362b1be","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T16:59:20Z","timestamp":1369846760000},"page":"799-809","source":"Crossref","is-referenced-by-count":8,"title":["Inhibitory impacts of chemically modified tetracycline-3 and underlying mechanism in human cervical cancer cells"],"prefix":"10.1097","volume":"24","author":[{"given":"Lin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saijun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-4-20210227","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.","volume":"2","author":"Golub","year":"1991","journal-title":"Crit Rev Oral Biol Med"},{"key":"R5-4-20210227","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.10168","article-title":"Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model.","volume":"98","author":"Lokeshwar","year":"2002","journal-title":"Int J Cancer"},{"key":"R6-4-20210227","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/0929867013373642","article-title":"Inhibition of tumor cell invasiveness by chemically modified tetracyclines.","volume":"8","author":"Gu","year":"2001","journal-title":"Curr Med Chem"},{"key":"R7-4-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1749-6632.1999.tb07690.x","article-title":"MMP inhibition in prostate cancer.","volume":"878","author":"Lokeshwar","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"R8-4-20210227","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/08959374980120012901","article-title":"Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.","volume":"12","author":"Lokeshwar","year":"1998","journal-title":"Adv Dent Res"},{"key":"R9-4-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/0929867013373516","article-title":"Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3).","volume":"8","author":"Lokeshwar","year":"2001","journal-title":"Curr Med Chem"},{"key":"R10-4-20210227","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1006732424102","article-title":"Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells.","volume":"18","author":"Meng","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"R12-4-20210227","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1749-6632.1999.tb07760.x","article-title":"CMT-3 a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer.","volume":"878","author":"Selzer","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"R13-4-20210227","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2010.11.003","article-title":"Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers.","volume":"63","author":"Lokeshwar","year":"2011","journal-title":"Pharmacol Res"},{"key":"R15-4-20210227","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fonc.2012.00171","article-title":"The interplay between autophagy and ROS in tumorigenesis.","volume":"2","author":"Kongara","year":"2012","journal-title":"Front Oncol"},{"key":"R16-4-20210227","first-page":"363","article-title":"Mechanism of mitochondrial membrane permeabilization during apoptosis under photofrin-mediated photodynamic therapy.","volume":"20","author":"Wu","year":"2012","journal-title":"J Xray Sci Technol"},{"key":"R17-4-20210227","first-page":"165","article-title":"Caspase control: protagonists of cancer cell apoptosis.","volume":"34","author":"Fiandalo","year":"2012","journal-title":"Exp Oncol"},{"key":"R19-4-20210227","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bmc.2012.10.051","article-title":"Molecular docking and synthesis of novel quinazoline analogues as inhibitors of transcription factors NF-kappaB activation and their anti-cancer activities.","volume":"21","author":"Xu","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"R20-4-20210227","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1745-7254.2007.00612.x","article-title":"Dihydroartemisinin is an inhibitor of ovarian cancer cell growth.","volume":"28","author":"Jiao","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"R21-4-20210227","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.1021\/jp3079748","article-title":"Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study.","volume":"116","author":"Marcial","year":"2011","journal-title":"J Phys Chem B"},{"key":"R22-4-20210227","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mc.20116","article-title":"Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis.","volume":"44","author":"Venkatraman","year":"2005","journal-title":"Mol Carcinog"},{"key":"R23-4-20210227","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3835(96)04362-5","article-title":"High-risk HPV-positive human cancer cell lines show different sensitivity to cisplatin-induced apoptosis correlated with the p21Waf1Cip1 level.","volume":"108","author":"Funaoka","year":"1996","journal-title":"Cancer Lett"},{"key":"R24-4-20210227","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/(SICI)1097-0215(19971114)73:4<592::AID-IJC22>3.0.CO;2-A","article-title":"Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines.","volume":"73","author":"Burger","year":"1997","journal-title":"Int J Cancer"},{"key":"R25-4-20210227","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.freeradbiomed.2012.12.024","article-title":"Reactive oxygen species generated in different compartments induce cell death, survival or senescence.","volume":"57","author":"Panieri","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"R27-4-20210227","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jcb.21655","article-title":"Reactive oxygen species: current knowledge and applications in cancer research and therapeutic.","volume":"104","author":"Lau","year":"2008","journal-title":"J Cell Biochem"},{"key":"R28-4-20210227","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/01635581.2012.712735","article-title":"Stevioside induced ROS-mediated apoptosis through mitochondrial pathway in human breast cancer cell line MCF-7.","volume":"64","author":"Paul","year":"2012","journal-title":"Nutr Cancer"},{"key":"R29-4-20210227","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.tiv.2012.12.011","article-title":"Antioxidant properties of Neu2000 on mitochondrial free radicals and oxidative damage.","volume":"27","author":"Visavadiya","year":"2012","journal-title":"Toxicol In Vitro"},{"key":"R32-4-20210227","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy.","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"R33-4-20210227","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/ijc.21447","article-title":"Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells.","volume":"118","author":"Onoda","year":"2006","journal-title":"Int J Cancer"},{"key":"R34-4-20210227","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.168.8.3902","article-title":"Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells.","volume":"168","author":"Herold","year":"2002","journal-title":"J Immunol"},{"key":"R35-4-20210227","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BSR20110043","article-title":"Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-kappaB signalling in lymphoma-bearing mice.","volume":"32","author":"Das","year":"2012","journal-title":"Biosci Rep"},{"key":"R36-4-20210227","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","article-title":"NF-kappaB at the crossroads of life and death.","volume":"3","author":"Karin","year":"2002","journal-title":"Nat Immunol"},{"key":"R38-4-20210227","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1126\/science.1098387","article-title":"Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit.","volume":"304","author":"Ducut","year":"2004","journal-title":"Science"},{"key":"R39-4-20210227","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1074-5521(01)00049-7","article-title":"The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.","volume":"8","author":"Kwok","year":"2001","journal-title":"Chem Biol"},{"key":"R40-4-20210227","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/MCB.15.5.2612","article-title":"Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.","volume":"15","author":"Ohtsubo","year":"1995","journal-title":"Mol Cell Biol"},{"key":"R42-4-20210227","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrc1881","article-title":"Ubiquitin ligases: cell-cycle control and cancer.","volume":"6","author":"Nakayama","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R43-4-20210227","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2010.05.078","article-title":"F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.","volume":"139","author":"Sancho","year":"2010","journal-title":"Gastroenterology"},{"key":"R44-4-20210227","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10555-011-9330-z","article-title":"Role of the ubiquitin ligase Fbw7 in cancer progression.","volume":"31","author":"Cheng","year":"2012","journal-title":"Cancer Metastasis Rev"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0b013e328362b1be","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:18:29Z","timestamp":1620947909000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201309000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e328362b1be","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}